{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.93","upperLimit":"0.99","value":"0.97"},{"groupId":"OG001","lowerLimit":"0.90","upperLimit":"0.99","value":"0.97"},{"groupId":"OG002","lowerLimit":"0.89","upperLimit":"0.99","value":"0.97"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"164"},{"groupId":"OG001","value":"81"},{"groupId":"OG002","value":"80"}],"units":"Participants"}],"description":"Survival from enrollment to death.","dispersionType":"95% Confidence Interval","groups":[{"description":"All Patients","id":"OG000","title":"Group 1"},{"description":"Regimen I","id":"OG001","title":"Group 2"},{"description":"Regimen II","id":"OG002","title":"Group 3"}],"paramType":"NUMBER","populationDescription":"164 Group 1 All Patients received induction therapy. 161 patients began consolidation therapy: 81 Group 2 Regimen I and 80 Group 3 Regimen II.","reportingStatus":"POSTED","timeFrame":"At 3 years from enrollment","title":"Overall Survival","type":"SECONDARY","unitOfMeasure":"Probability of survival"}